Fulfillium, Inc. v. ReShape Medical, Inc. et al.

After Gardella Grace refined and sharpened a portfolio of patents directed to novel medical devices, our team, led by Principal Cook Alciati, successfully enforced the new patents and related trade secrets in the United States District Court for the Central District of California.  The last defendant settled day before trial resulting in a seven figure settlement that equated to a 60 percent royalty on sales of the accused product.  Principal Greg Gardella led the prosecution effort after taking over the portfolio just a few years before patent expiration and led the effort at the Patent Trial and Appeal Board to defeat multiple petitions for inter partes review, which were denied before institution.


The inter partes review brief (Patent Owner Preliminary Response) can be found here.

A representative complaint can be found here.